Related Experiment Video
Updated: Aug 13, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Severe acute respiratory syndrome and tuberculosis
1Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco General Hospital, 1001 Potrero Avenue, Room 3C-38, San Francisco, CA 94110, USA. stackr@anesthesia.ucsf.edu
This article reviews respiratory infectious diseases like severe acute respiratory syndrome (SARS) and tuberculosis (TB), detailing their history, symptoms, and treatment. It provides guidance on infection control to prevent secondary transmission in healthcare settings.
Area of Science:
- Infectious Diseases
- Public Health
- Respiratory Medicine
Background:
- Respiratory infectious diseases, including severe acute respiratory syndrome (SARS) and tuberculosis (TB), pose significant health risks.
- Understanding the historical context of these diseases is crucial for effective management.
- Exposure to these pathogens necessitates robust infection control measures.
Purpose of the Study:
- To provide a comprehensive overview of SARS and TB.
- To discuss the pathogenesis, clinical manifestations, and therapeutic strategies for these diseases.
- To outline recommendations for preventing secondary transmission in healthcare facilities.
Main Methods:
- Literature review of historical data on SARS and TB.
- Analysis of pathogenesis and clinical manifestations.
- Synthesis of current therapeutic approaches.
- Review of Centers for Disease Control and Prevention (CDC) guidelines for infection control.
Main Results:
- Detailed historical background of SARS and TB provided.
- Pathogenesis and key manifestations of each disease are explained.
- Current therapeutic options are discussed.
- Evidence-based recommendations for limiting secondary transmission are presented.
Conclusions:
- Effective management of SARS and TB requires understanding their history, pathology, and clinical presentation.
- Adherence to CDC infection control guidelines is essential for preventing healthcare-associated transmission.
- Public health strategies must address the unique risks associated with these respiratory infectious diseases.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
03:53Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV
Published on: November 10, 2023
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Coronavirus